漂浮性右心血栓:过去10年病例的汇总分析
该汇总分析系统检索了2006至2016年报告的漂浮性右心血栓临床病例,共纳入207例患者,中位年龄60岁,男性51.7%,31.4%表现为休克,85%合并肺血栓栓塞症。治疗方式包括单纯抗凝44例(21.28%)、外科取栓89例(43%)、溶栓66例(31.8%)、经皮血栓清除3例(1.93%)和原位纤溶4例(1.45%)。总体死亡率为21.3%,单纯抗凝相关死亡率高于外科取栓或溶栓(分别为36.4%、18%、18.2%,p=0.03)。多因素分析显示,仅单纯抗凝(OR 2.4,95%CI 1.07-5.4,p=0.03)和休克(OR 2.87,95%CI 1.3-5.9,p=0.005)对死亡率有统计学显著影响。作者认为单纯抗凝似乎不足,溶栓与外科取栓结果更好且相似,需个体化权衡两者风险与获益。
要点
- 207例漂浮性右心血栓患者中31.4%表现为休克,总体死亡率为21.3%。
- 单纯抗凝治疗死亡率36.4%,高于外科取栓的18%和溶栓的18.2%(p=0.03)。
- 多因素分析中仅单纯抗凝(OR 2.4,95%CI 1.07-5.4,p=0.03)和休克(OR 2.87,95%CI 1.3-5.9,p=0.005)与死亡率显著相关。
- 85%的病例合并肺血栓栓塞症,提示需同时评估肺栓塞。
- 经皮血栓清除3例和原位纤溶4例的死亡率均为0%。
适用人群与场景
- 2006至2016年报告的漂浮性右心血栓临床病例,共207例,中位年龄60岁,男性51.7%。
处置流程与药物剂量
- 治疗方式包括单纯抗凝44例(21.28%)、外科取栓89例(43%)、溶栓66例(31.8%)、经皮血栓清除3例(1.93%)和原位纤溶4例(1.45%)。
红旗征与不能漏的情况
- 31.4%的患者表现为休克,多因素分析中休克与死亡率显著相关(OR 2.87,95%CI 1.3-5.9,p=0.005)。
研究设计与关键结果
- 系统检索2006至2016年报告的漂浮性右心血栓临床病例,共分析207例患者。
- 总体死亡率为21.3%;单纯抗凝相关死亡率为36.4%,外科取栓为18%,溶栓为18.2%(p=0.03)。
- 经皮血栓清除3例和原位纤溶4例的死亡率均为0%。
- 多因素分析显示,仅单纯抗凝(OR 2.4,95%CI 1.07-5.4,p=0.03)和休克(OR 2.87,95%CI 1.3-5.9,p=0.005)对死亡率有统计学显著影响。
- 85%的病例合并肺血栓栓塞症。
证据类型、等级与局限
- 证据类型:对2006至2016年报告临床病例的汇总分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,单纯抗凝作为唯一策略似乎不足,溶栓和外科取栓显示更好且相似的结果。
- 作者认为,需个体化权衡溶栓与外科取栓两种技术的风险与获益,以选择最适合患者的策略。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Floating right heart thrombi (FRHTS) are a rare phenomenon associated with high mortality. Immediate treatment is mandatory, but optimal therapy is controversial.
OBJECTIVE: To compare the clinical characteristics according to different treatment strategies and to identify predictors of mortality on patients with FRHTS.
METHODS: We conducted a systematic search of reported clinical cases of TTRH from 2006 to 2016.
RESULTS: 207 patients were analyzed, median age was 60years, 51.7% were men, 31.4% presented with shock. Pulmonary thromboembolism was present in 85% of the cases. The treatments administered were anticoagulation therapy in 44 patients (21.28%), surgical embolectomy in 89 patients (43%), thrombolytic therapy in 66 patients (31.8%), percutaneous thrombectomy in 3 patients (1.93%) and fibrinolytic in situ in 4 (1.45%). The overall mortality rate was 21.3%. The mortality associated with anticoagulation alone was higher than surgical embolectomy or thrombolysis (36.4 vs 18% vs 18.2%, respectively, p=0.03), and in percutaneous thrombectomy and fibrinolytics in situ was 0%. At multivariate analysis, only anticoagulation alone (odds ratio [OR] 2.4, IC 95% 1.07-5.4, p=0.03), and shock (OR 2.87 (IC 95% 1.3-5.9, p=0.005) showed a statistically significant effect on mortality.
CONCLUSION: FRHTS represent a serious form of thromboembolism that requires rapid decisions to improve the survival. Anticoagulation as the only strategy does not seem to be sufficient, while thrombolysis and surgical thrombectomy show better and similar results. A proper individualization of the risk and benefits of both techniques is necessary to choose the most appropriate strategy for our patients.
参考来源
- Burgos LM, Costabel JP, Galizia Brito V, et al. Floating right heart thrombi: A pooled analysis of cases reported over the past 10years. Am J Emerg Med. 2017. PMID: 29111332. doi:10.1016/j.ajem.2017.10.045
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。